홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diphenylmethane diisocyanate → Bromocriptine

HRID 729201
인쇄

반응식

HRID 729201 반응식
C1C(CC2C=CC(N=C=O)=CC=2)=CC=C(N=C=O)C=1.[CH3:20][CH:21]([CH2:23][C@@H:24]1[N:33]2[C:34]([C@@:36]([NH:41][C:42]([C@@H:44]3[CH:60]=[C:59]4[C@@H:47]([CH2:48][C:49]5[C:50]6[C:51]4=[CH:52][CH:53]=[CH:54][C:55]=6[NH:56][C:57]=5[Br:58])[N:46]([CH3:61])[CH2:45]3)=[O:43])([CH:38]([CH3:40])[CH3:39])[O:37][C@@:32]2([OH:62])[C@H:31]2[N:27]([CH2:28][CH2:29][CH2:30]2)[C:25]1=[O:26])=[O:35])[CH3:22].CS(O)(=O)=O>>[CH3:22][CH:21]([CH2:23][C@@H:24]1[N:33]2[C:34]([C@@:36]([NH:41][C:42]([C@@H:44]3[CH:60]=[C:59]4[C@@H:47]([CH2:48][C:49]5[C:50]6[C:51]4=[CH:52][CH:53]=[CH:54][C:55]=6[NH:56][C:57]=5[Br:58])[N:46]([CH3:61])[CH2:45]3)=[O:43])([CH:38]([CH3:39])[CH3:40])[O:37][C@@:32]2([OH:62])[C@H:31]2[N:27]([CH2:28][CH2:29][CH2:30]2)[C:25]1=[O:26])=[O:35])[CH3:20]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 7570Diphenylmethane diisocyanateHCID 31100Bromocriptine Mesylate

생성물 1

HCID 31101Bromocriptine

실험 절차

The formulations were tested on an Andersen™ cascade impactor to determine their aerodynamic particle properties. The cascade impactor was operated at 28.3 I/min and fitted with a USP induction port (<USP 601> Pharmacopeial Previews 22, 3065 (1995)). The particle size distributions were fractionated into mass of drug deposited on the pMDI actuator, USP induction port, eight stages and terminal filter. Five shots were actuated per test, with an interval of at least 30 seconds between shots to prevent cooling of the can and resultant moisture condensation. The bromocriptine content in each sample was determined by HPLC. The percentage of the total dose deposited from stage 4 to the terminal filter (corresponding to particles of MMAD less than 3.3 μm) was considered to be the fine particle fraction.

후처리

  1. customfitted with a USP induction port (<USP 601> Pharmacopeial Previews 22, 3065 (1995))
  2. filtrationfilter
  3. customwere actuated per test, with an interval of at least 30 seconds between shots
  4. temperatureto prevent cooling of the can
  5. customresultant moisture condensation
  6. filtrationfilter (corresponding to particles of MMAD less than 3.3 μm)

출처 및 근거

ORD 기록
ord-105bc92990b24b3d9a6b481443a8c1a0
출처 데이터셋
uspto-grants-2009_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07582284B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트